CARMENA Trial Randomized Patients | Either Tyrosine-Kinase Inhibitor, or Surgery & Sunitnib

CARMENA Trial Randomized Patients | Either Tyrosine-Kinase Inhibitor, or Surgery & Sunitnib

User Photo
Annual-Meeting

2 years
184 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Aly-Khan A. Lalani, MD, FRCPC Juravinski Cancer Centre, explains CARMENA Trial Randomized Patients | Either Tyrosine-Kinase Inhibitor, or Surgery & Sunitnib at Annual Meeting 2018
Autoplay ended Autoplay